Rawstron AC - Search Results

1

Minimal residual disease is an independent predictor for 10-year survival in CLL.

Kwok M, Rawstron AC, Varghese A, Evans PA, O'Connor SJ, Doughty C, Newton DJ, Moreton P, Hillmen P. Kwok M, et al. Among authors: rawstron ac. Blood. 2016 Dec 15;128(24):2770-2773. doi: 10.1182/blood-2016-05-714162. Epub 2016 Oct 3. Blood. 2016. PMID: 27697770 Free article.

2

Assessment of IgH PCR strategies in multiple myeloma.

Owen RG, Johnson RJ, Rawstron AC, Evans PA, Jack A, Smith GM, Child JA, Morgan GJ. Owen RG, et al. Among authors: rawstron ac. J Clin Pathol. 1996 Aug;49(8):672-5. doi: 10.1136/jcp.49.8.672. J Clin Pathol. 1996. PMID: 8881921 Free PMC article.

3

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ. Rawstron AC, et al. Br J Haematol. 1997 Apr;97(1):46-55. doi: 10.1046/j.1365-2141.1997.72653.x. Br J Haematol. 1997. PMID: 9136941 Free article.

4

FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells.

Davies FE, Rawstron AC, Pratt G, O'Connor S, Su'ut L, Blythe D, Fenton J, Claydon D, Child JA, Jack AS, Morgan GJ. Davies FE, et al. Among authors: rawstron ac. Br J Haematol. 1999 Jul;106(1):40-6. doi: 10.1046/j.1365-2141.1999.01506.x. Br J Haematol. 1999. PMID: 10444161 Free article.

5

The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.

Rawstron AC, Rollinson SJ, Richards S, Short MA, English A, Morgan GJ, Hale G, Hillmen P. Rawstron AC, et al. Br J Haematol. 1999 Oct;107(1):148-53. doi: 10.1046/j.1365-2141.1999.01676.x. Br J Haematol. 1999. PMID: 10520035 Free article.

6

Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria.

Richards SJ, Rawstron AC, Hillmen P. Richards SJ, et al. Among authors: rawstron ac. Cytometry. 2000 Aug 15;42(4):223-33. Cytometry. 2000. PMID: 10934341 Review.

7

The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.

Rawstron AC, Fenton JA, Ashcroft J, English A, Jones RA, Richards SJ, Pratt G, Owen R, Davies FE, Child JA, Jack AS, Morgan G. Rawstron AC, et al. Blood. 2000 Dec 1;96(12):3880-6. Blood. 2000. PMID: 11090073 Free article.

8

The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma.

Davies FE, Forsyth PD, Rawstron AC, Owen RG, Pratt G, Evans PA, Richards SJ, Drayson M, Smith GM, Selby PJ, Child JA, Morgan GJ. Davies FE, et al. Among authors: rawstron ac. Br J Haematol. 2001 Mar;112(3):814-9. doi: 10.1046/j.1365-2141.2001.02530.x. Br J Haematol. 2001. PMID: 11260088 Free article.

9

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy.

Rawstron AC, Kennedy B, Evans PA, Davies FE, Richards SJ, Haynes AP, Russell NH, Hale G, Morgan GJ, Jack AS, Hillmen P. Rawstron AC, et al. Blood. 2001 Jul 1;98(1):29-35. doi: 10.1182/blood.v98.1.29. Blood. 2001. PMID: 11418459 Free article.

10

Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia.

Kennedy B, Rawstron A, Carter C, Ryan M, Speed K, Lucas G, Hillmen P. Kennedy B, et al. Blood. 2002 Mar 15;99(6):2245-7. doi: 10.1182/blood.v99.6.2245. Blood. 2002. PMID: 11877305 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters